Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain

  1. Frías, C.
  2. Cortés, J.
  3. Seguí, M.Á.
  4. Oyagüez, I.
  5. Casado, M.Á.
Zeitschrift:
Clinical and Translational Oncology

ISSN: 1699-048X

Datum der Publikation: 2010

Ausgabe: 12

Nummer: 10

Seiten: 692-700

Art: Artikel

DOI: 10.1007/S12094-010-0579-4 GOOGLE SCHOLAR